BILLERICA, Mass., May 24, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (CFMS), a leading medical device company that features personalized knee and hip replacement products, today announced results of a ...

BILLERICA, Mass., May 10, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) today announced 510(k) clearance by the U.S. Food and Drug Administration for the Company’s Identity Imprint Knee ...

BILLERICA, Mass., Jan. 30, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, ...

BILLERICA, Mass., March 21, 2023 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), a leading medical technology company featuring personalized knee and hip replacement products, recently launched a ...

The first procedure using the new Conformis Identity Imprint knee replacement system was completed this week at the Stratham (N.H.) Ambulatory Surgical Center. The new system from Conformis uses an ...

Knee replacements are a fact of aging. Conformis, a Boston-based medical tech company, produced personalized joint replacement for knees and hips. The goal is less pain and faster recoveries. Eicoff ...

The ConforMIS iTotal CR Knee Replacement System uses iFit technology to create patient-specific systems. It is designed to provide patients and surgeons with a more anatomic, personalized solution to ...

LONDON--(BUSINESS WIRE)--The global knee replacement market is expected to grow by USD 2.26 billion during 2020-2024, progressing at a CAGR of almost 5% during the forecast period. The growth can be ...

Leveraging Conformis’ extensive library of personalized knee design data and patient images, Identity Imprint is designed to match patients’ anatomy with an optimal arthroplasty solution while at the ...